Join our Community
Support ToI and remove all ads
Learn more

ISRAEL AT WAR - DAY 564

Alzheimer's disease

How often can you swallow? (Photo by iStock)
April 11, 2025, 3:05 pm
How often can you swallow? Israeli-improved test can screen for neurological disorders
Kaplan Medical Center researchers establish a baseline number of swallows for healthy people depending on their age, enabling more effective use of the Repetitive Saliva Swallowing Test
By Diana Bletter
Prof. Naomi Habib, Hebrew University in Jerusalem, with Ph.D. student Gilad Green. (Yonit Schiller)
September 6, 2024, 12:23 pm
In game-changer, Israeli researchers find Alzheimer’s markers 20 years before onset
Hebrew University-led team maps 1.65 million brain cells from 437 aging brains; innovative algorithms predict brain cells’ trajectories, bringing ‘much more hope of a cure’
By Diana Bletter
Illustrative image of a doctor comforting a patient with Alzheimer's Disease. (Chinnapong, iStock by Getty Images)
May 8, 2024, 10:24 pm
Study seeks to explain why Sephardi Jews more likely to get early-onset Alzheimer’s
NIH grants $13 million for genetic research after 2018 research showed Jews with roots in Spain, Middle East and North Africa see far more cases of early cognitive decline
By Renee Ghert-Zand
Illustrative: A woman undergoing an MRI scan (Povozniuk via iStock by Getty Images)
September 20, 2023, 6:05 pm
Israeli researchers develop noninvasive method to assess iron levels in brain
Using MRI images and physical calculations, team led by Hebrew University PhD student gains vital data previously available only via autopsy or tissue sample examinations
By Renee Ghert-Zand
This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi (Eisai via AP, File)
July 8, 2023, 7:32 pm
Novel Alzheimer’s drug gets full FDA approval, though efficacy and risk questioned
Leqembi is first medicine convincingly shown to modestly slow cognitive decline, but some experts say effect too subtle, note dangers
By AP and ToI Staff
FILE: With the Dome of the Rock on the right, an Israeli man covered in a flag watches Israelis wave the national flag as they march in the Jerusalem Day parade in Jerusalem Old City, June 1, 2011. (AP Photo/Ariel Schalit)
May 18, 2023, 1:06 pm
Daily Briefing May 18: The Jerusalem Day Flag March — celebration or provocation?
Senior analyst Haviv Rettig Gur on today’s parade through the Muslim Quarter and the ultra-Orthodox budget; health reporter Renee Ghert-Zand on cancer and Alzheimer’s innovations
By ToI Staff
Animation: Alzheimer's disease brain shrinkage. (National Institute on Aging, Public domain, via Wikimedia Commons)
May 11, 2023, 11:00 am
Israeli study reveals molecular basis for female Alzheimer’s patients’ rapid decline
Research done at Hebrew University could lead to better understanding of genetic origins of the disease, as well as treatments to prevent or slow cognitive deterioration
By Renee Ghert-Zand
Israel Prize recipient Prof. Michal Schwartz blazes a trail toward anti-aging treatment through immune therapy (Courtesy of Weizmann Institute of Science)
April 26, 2023, 6:38 am
For scientist Michal Schwartz, Israel Prize is rewarding milestone in ongoing journey
Weizmann Institute neuroimmunologist bucked convention to prove that brain is not isolated from immune system, leading to possible therapies to treat Alzheimer’s and other diseases
By Renee Ghert-Zand
Illustration of the human microbiome. (Design Cells via iStock by Getty Images)
April 17, 2023, 4:41 pm
Hangry bacteria in gut microbiome linked to chronic disease
Bacteria living in our digestive tracts remain hungry for critical nutrients missing in the American diet
By Christopher Damman
Israelis attend a Passover seder in Mishmar David, April 15, 2022. (Nati Shohat/Flash90)
April 3, 2023, 4:32 pm
New Passover guide aims to help families with loved ones living with dementia
Tzohar and Emda organizations team up to provide practical guidance on how to follow Jewish law while including the ill in holiday traditions as best as possible
By Renee Ghert-Zand
Illustrative image: A human brain with degeneration, which is denoted in green. (Naeblys via iStock by Getty Images)
February 21, 2023, 10:14 pm
Israeli scientists say they cured mice of Alzheimer’s using newly developed molecule
Effectiveness shown via behavior tests and brain analysis, say authors of research; they stress it’s a small sample and progress to human drug, if successful, will take time
By Nathan Jeffay
FILE - In this Aug. 14, 2018 file photo, a doctor looks at PET brain scans in Phoenix (AP Photo/Matt York, File)
November 30, 2022, 12:08 pm
In first, new Alzheimer’s drug modestly slows progress of disease, researchers say
US, Japanese drugmakers announce results of full study, but remains unclear how much of a difference it may make to lives of those affected by the condition
By LAURAN NEERGAARD
University of Maine climate scientist Jacquelyn Gill examines a cone from a western pine at the Sawyer Environmental Research Center, May 4, 2022, in Orono, Maine. (AP Photo/ Robert F. Bukaty)
May 8, 2022, 8:21 pm
How climate scientists keep hope alive as damage worsens
Psychologists say average person can learn from and use methods employed by professionals in tough and demanding fields
By Seth Borenstein
A 3D render of a brain (Kirsty Pargeter. via iStock by Getty Images)
December 8, 2021, 1:03 pm
Israeli drug candidate slows Alzheimer’s-causing protein in mouse brains
Scientists say their lab results could make their compound a promising drug for combating dementia, possibly also autism
By Nathan Jeffay
One of the best-known people to suffer from ALS was the late Professor Stephen Hawking. (Photo by Joel Ryan/Invision/AP)
November 2, 2021, 10:55 am
Israeli drug that slowed Alzheimer’s, ALS in mice gets funding to start trials
Molecules ‘amazing’ in delaying onset and progression of the conditions in mice, says researcher; if they’re 10% as effective in humans they’ll become a ‘very good drug’
By Nathan Jeffay
Load More
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.